関連する実験動画
Updated: Jun 12, 2026

06:09
Assaying the Kinase Activity of LRRK2 in vitro
Published on: January 18, 2012
イディオパシーパーキンソン病における一般的なLRRK2変異
William P Gilks1, Patrick M Abou-Sleiman, Sonia Gandhi
1Department of Molecular Neuroscience, Institute of Neurology and National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, UK.
Lancet (London, England)
|February 1, 2005
まとめ
常見のルシンの豊富なリピートキナーゼ2 (LRRK2) 遺伝子変異であるGly2019Serは,イディオパシーパーキンソン病患者の1.6%で発見されました. この発見は,散発的なパーキンソン病における単一のメンデルの変異を意味しています.
科学分野:
- 遺伝学 遺伝学とは
- 神経学 神経学とは
- 分子生物学は分子生物学である.
背景:
- レウシンに富んだリピートキナーゼ2 (LRRK2) 遺伝子の変異は,自己相性優位性パーキンソン病の既知の原因である.
- 特定の変異を特定することは,病気のメカニズムを理解し,標的治療を開発するために不可欠です.
研究 の 目的:
- 病原性パーキンソン病の患者における一般的なLRRK2 Gly2019Ser変異の頻度を調査する.
- この特定の変異が病気の散発的形態に寄与するかどうかを判断する.
主な方法:
- LRRK2遺伝子のエクソン41の直接シーケンシングは,イディオパシーパーキンソン病の482人の患者に実施した.
- パーキンソン病の病理学的確認は,評価された263人の患者のために利用可能でした.
主要な成果:
- LRRK2 Gly2019Ser変異は,パーキンソン病患者の8人 (1.6%) で特定されました.
- これは,この変異と散発性パーキンソン病の間の有意な関連性を示しています.
結論:
- 一般的な単一のメンデルの変異 (LRRK2 Gly2019Ser) は,散発性パーキンソン病に関連しています.
- この変異の検査は,パーキンソン病の患者の管理を改善し,パーキンソン病の症例における遺伝カウンセリングのために推奨されます.
関連する概念動画
Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Alternative RNA Splicing
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Lysosomal Hydrolases
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Lethal Alleles
Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...

